Back to Results
First PageMeta Content
Ivacaftor / Phenols / Quinolones / Pharmaceutical Benefits Scheme / Cystic fibrosis / Vertex Pharmaceuticals / Clinical trial / Spirometry / Health / Medicine / Anilides


Document Date: 2015-03-23 21:11:42

Open Document

File Size: 236,11 KB

Share Result on Facebook

Company

Vertex Pharmaceuticals (Australia) Pty Ltd / New England Journal / The PBAC / Donaldson / /

Country

Australia / /

Currency

USD / /

Event

FDA Phase / Product Recall / Reorganization / Product Issues / /

Holiday

Commonwealth Day / /

IndustryTerm

treatment of cystic fibrosis / /

MedicalCondition

accredited pulmonary function laboratory / cystic fibrosis transmembrane regulator / cystic fibrosis transmembrane conductance regulator / Subjects With Cystic Fibrosis / cystic fibrosis / acute infection / chronic sinopulmonary disease / chronic conditions / /

MedicalTreatment

antibiotics / /

Organization

Pharmaceutical Benefits Advisory Committee / Department of Human Services / Therapeutic Goods Administration / Australian Government / Thoracic Society of Australia and New Zealand / /

/

Position

Boyle MP / principal driver / /

Product

Predicted The PBAC / G551D / VX10 / VX08 / /

ProgrammingLanguage

RC / ML / /

PublishedMedium

New England Journal of Medicine / /

RadioStation

CFTR / /

Region

New England / /

Technology

pharmacokinetics / /

SocialTag